Publication:
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach.

Simple item page
cris.virtual.author-orcid0000-0003-4474-3132
cris.virtual.author-orcid0000-0003-3820-0297
cris.virtual.author-orcid0000-0001-5897-3647
cris.virtualsource.author-orcid54bd7a3a-74e3-48ff-aa94-8a4dfd2a6e9b
cris.virtualsource.author-orcid023792ec-f660-4a68-905d-3d93f245f2fa
cris.virtualsource.author-orcida29b827e-68ac-43af-a487-f76e843b2f6c
cris.virtualsource.author-orcidc441561b-2f62-41ef-8e09-fb335467e1b9
cris.virtualsource.author-orcidecf89b10-ddb5-4544-a9c3-895f34205b9b
cris.virtualsource.author-orcidea5070c5-002b-4d1b-b684-c22e886243b0
cris.virtualsource.author-orcidd7eb2525-1641-41ca-a6fd-9f24a69b7f24
cris.virtualsource.author-orcid4cb402ea-7dca-4848-9a8a-3f49f6d6e920
datacite.rightsopen.access
dc.contributor.authorMandhair, Harpreet Kaur
dc.contributor.authorRadpour, Ramin
dc.contributor.authorWesterhuis, Mira
dc.contributor.authorBanz Wälti, Yara Sarah
dc.contributor.authorHumbert, Magali
dc.contributor.authorArambasic, Miroslav
dc.contributor.authorDengjel, Jörn
dc.contributor.authorDavies, Andrew
dc.contributor.authorTschan, Mario Paul
dc.contributor.authorNovak, Urban
dc.date.accessioned2024-10-26T17:06:21Z
dc.date.available2024-10-26T17:06:21Z
dc.date.issued2024-02
dc.description.noteAntwort Meddek: Für 'Nature/Leukemia' kann dies als Kat. A angenommen werden, 24.06.2025
dc.description.numberOfPages6
dc.description.sponsorshipInstitut für Gewebemedizin und Pathologie - Immunpathologie 5
dc.description.sponsorshipUniversitätsklinik für Medizinische Onkologie
dc.description.sponsorshipDepartment for BioMedical Research, Forschungsgruppe Tumor-Immunologie
dc.description.sponsorshipInstitut für Gewebemedizin und Pathologie
dc.identifier.doi10.48350/192057
dc.identifier.pmid38263431
dc.identifier.publisherDOI10.1038/s41375-024-02147-4
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/173737
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.ispartofLeukemia
dc.relation.issn0887-6924
dc.relation.organizationDCD5A442BE58E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C448E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C453E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BF89E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BE2AE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C3DBE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD18E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C252E17DE0405C82790C4DE2
dc.relation.schoolDCD5A442C27BE17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc500 - Science::570 - Life sciences; biology
dc.titleAnalysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage429
oaire.citation.issue2
oaire.citation.startPage424
oaire.citation.volume38
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
oairecerif.author.affiliationDepartment for BioMedical Research, Forschungsgruppe Tumor-Immunologie
oairecerif.author.affiliationInstitut für Gewebemedizin und Pathologie
oairecerif.author.affiliationInstitut für Gewebemedizin und Pathologie
oairecerif.author.affiliationInstitut für Gewebemedizin und Pathologie - Immunpathologie 5
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
oairecerif.author.affiliationInstitut für Gewebemedizin und Pathologie - Immunpathologie 5
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
oairecerif.author.affiliation2Department for BioMedical Research (DBMR)
oairecerif.author.affiliation2Universitätsklinik für Medizinische Onkologie
oairecerif.author.affiliation2Institut für Gewebemedizin und Pathologie - Klinische Pathologie
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
oairecerif.author.affiliation2Institut für Gewebemedizin und Pathologie
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2024-01-25 15:17:50
unibe.description.ispublishedpub
unibe.eprints.legacyId192057
unibe.journal.abbrevTitleLEUKEMIA
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
s41375-024-02147-4.pdf
Size:
1.5 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published
Download

Collections

Publications